This is an observational study to understand the treatment with sofosbuvir-based therapy of persons with hepatitis C. The treating physician must be part of participating clinic—see locations in the ClinicalTrials.gov website.
India: Safety and Efficacy of Sofosbuvir-based Regimens in Clinical Practice for the Treatment of Chronic Hepatitis C Virus Infection in India
To view the entire clinical trial information, click here
The study is evaluating the dose of sofosbuvir plus ribavirin in adolescent patients—aged 12 to 17 yo—infected with HCV genotype 2 and 3. Once the dose is determined the same adolescent patients will be treated with the combination of sofosbuvir plus ribavirin.
Safety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children With Genotype 2 or 3 Chronic HCV Infection
To view the entire clinical trial description, click here